Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article published on 3 June 2017 |
| Author/s |
author: Gebra Cuyun Carter Oscar Arrieta |
| Publication date | June 3, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |